SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-24-000023
Filing Date
2024-05-20
Accepted
2024-05-20 06:55:47
Documents
18
Period of Report
2024-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20240514x8k.htm   iXBRL 8-K 45745
2 EX-4.1 ibio-20240514xex4d1.htm EX-4.1 115519
3 EX-10.1 ibio-20240514xex10d1.htm EX-10.1 323903
4 EX-10.2 ibio-20240514xex10d2.htm EX-10.2 529976
5 EX-10.3 ibio-20240514xex10d3.htm EX-10.3 51075
  Complete submission text file 0001420720-24-000023.txt   1368741

Data Files

Seq Description Document Type Size
6 EX-101.SCH ibio-20240514.xsd EX-101.SCH 4159
7 EX-101.DEF ibio-20240514_def.xml EX-101.DEF 3258
8 EX-101.LAB ibio-20240514_lab.xml EX-101.LAB 13975
9 EX-101.PRE ibio-20240514_pre.xml EX-101.PRE 10318
22 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20240514x8k_htm.xml XML 4644
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 24962311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)